Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats

Veterinary Microbiology

Volumn 120, Issue 3-4, 2007, Pages 217-225

  Kusuhara, Hajime ^a,b   Hohdatsu, Tsutomu ^a   Seta, Takeshi ^a   Nemoto, Kaori ^a   Motokawa, Kenji ^b   Gemma, Tsuyoshi ^b   Watanabe, Rie ^b   Huang, Chengjin ^c   Arai, Setsuo ^b   Koyama, Hiroyuki ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO INSTITUTE   (Japan)

^c ZOETIS   (United States)

Author keywords

Dual subtype FIV vaccine; ELISA; Feline immunodeficiency virus; Serological differentiation

Indexed keywords

FORMALDEHYDE; MEMBRANE PROTEIN; RECOMBINANT ANTIGEN; VIRUS ANTIGEN; VIRUS VACCINE;

ACCURACY; ARTICLE; BLOOD SAMPLING; CAT; COMPARATIVE STUDY; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE IMMUNODEFICIENCY VIRUS; INOCULATION; NONHUMAN; OPTICAL DENSITY; SERODIAGNOSIS; STATISTICAL ANALYSIS; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAT DISEASES; CATS; DISCRIMINANT ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNODEFICIENCY VIRUS, FELINE; LENTIVIRUS INFECTIONS; VIRAL VACCINES;

FELINE IMMUNODEFICIENCY VIRUS;

EID: 33846850495     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2006.10.038     Document Type: Article

References (20)

1. Andersen P.R., and Tyrrell P. Feline immunodeficiency virus diagnosis after vaccination. Anim. Health Res. Rev. 5 (2004) 327-330
2. Bachmann M.H., Mathiason-Dubard C., Learn G.H., Rodrigo A.G., Sodora D.L., Mazzetti P., Hoover E.A., and Mullins J.I. Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades. J. Virol. 71 (1997) 4241-4253
3. Bendinelli M., Pistello M., Lombardi S., Poli A., Garzelli C., Matteucci D., Ceccherini-Nelli L., Malvaldi G., and Tozzini F. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8 (1995) 87-112
4. Connell S. Manufacture addresses concerns about FIV vaccine. J. Am. Vet. Med. Assoc. 222 (2003) 149
5. Elder J.H., Dean G.A., Hoover E.A., Hoxie J.A., Malim M.H., Mathes L., Neil J.C., North T.W., Sparger E., Tompkins M.B., Tompkins W.A., Yamamoto J., Yuhki N., Pedersen N.C., and Miller R.H. Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. AIDS Res. Hum. Retrov. 14 (1998) 797-801
6. Fontenot J.D., Hoover E.A., Elder J.H., and Montelaro R.C. Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis. J. Clin. Microbiol. 30 (1992) 1885-1890
7. Hohdatsu T., Okada S., Ishizuka Y., Yamada H., and Koyama H. The prevalence of types I and II feline coronavirus infections in cats. J. Vet. Med. Sci. 54 (1992) 557-562
8. Hohdatsu T., Okada S., Motokawa K., Aizawa C., Yamamoto J.K., and Koyama H. Effect of dual-subtype vaccine against feline immunodeficiency virus infection. Vet. Microbiol. 58 (1997) 155-165
9. Ishida T., Washizu T., Toriyabe K., Motoyoshi S., Tomoda I., and Pedersen N.C. Feline immunodeficiency virus infection in cats of Japan. J. Am. Vet. Med. Assoc. 194 (1989) 221-225
10. Kahler S.C. News. Delude of questions prompts AAFP to develop FIV vaccine brief. J. Am. Vet. Med. Assoc. 221 (2002) 1231-1234
11. Kakinuma S., Motokawa K., Hohdatsu T., Yamamoto J.K., Koyama H., and Hashimoto H. Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtype. J. Virol. 69 (1995) 3639-3646
12. Kusuhara H., Hohdatsu T., Okumura M., Sato K., Suzuki Y., Motokawa K., Gemma T., Watanabe R., Huang C., Arai S., and Koyama H. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats. Vet. Microbiol. 108 (2005) 155-165
13. Omori M., Pu R., Tanabe T., Hou W., Coleman J.K., Arai M., and Yamamoto J.K. Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine. Vaccine 23 (2004) 386-398
14. Pedersen N.C., Ho E.W., Brown M.L., and Yamamoto J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235 (1987) 790-793
15. Pu R., Coleman J., Omori M., Arai M., Hohdatsu T., Huang C., Tanabe T., and Yamamoto J.K. Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates. AIDS 15 (2001) 1225-1237
16. Pu R., Coleman J., Coisman J., Sato E., Tanabe T., Arai M., and Yamamoto J.K. Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate. J. Feline Med. Surg. 7 (2005) 65-70
17. Shen F., Chen P.D., Walfield A.M., Ye J., House J., Brown F., and Wang C.Y. Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA. Vaccine 17 (1999) 3039-3049
18. Steinrigl A., and Klein D. Phylogenetic analysis of feline immunodeficiency virus in Central Europe: a prerequisite for vaccination and molecular diagnostics. J. Gen. Virol. 84 (2003) 1301-1307
19. Uhl E.W., Heaton-Jones T.G., Pu R., and Yamamoto J.K. FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review. Vet. Immunol. Immunopathol. 90 (2002) 113-132
20. Willett B.J., Flynn J.N., and Hosie M.J. FIV infection of the domestic cat: an animal model for AIDS. Immunol. Today 18 (1997) 182-189